company background image

Mach7 Technologies ASX:M7T Stock Report

Last Price


Market Cap







19 May, 2022


Company Financials +
M7T fundamental analysis
Snowflake Score
Future Growth4/6
Past Performance0/6
Financial Health6/6

M7T Stock Overview

Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises worldwide.

Mach7 Technologies Peers

Price History & Performance

Summary of all time highs, changes and price drops for Mach7 Technologies
Historical stock prices
Current Share PriceAU$0.60
52 Week HighAU$1.11
52 Week LowAU$0.51
1 Month Change-18.92%
3 Month Change-18.92%
1 Year Change-43.66%
3 Year Change84.62%
5 Year Change233.33%
Change since IPO-4.76%

Recent News & Updates

Shareholder Returns

M7TAU Healthcare ServicesAU Market

Return vs Industry: M7T underperformed the Australian Healthcare Services industry which returned -18% over the past year.

Return vs Market: M7T underperformed the Australian Market which returned 2.1% over the past year.

Price Volatility

Is M7T's price volatile compared to industry and market?
M7T volatility
M7T Average Weekly Movement7.5%
Healthcare Services Industry Average Movement9.0%
Market Average Movement9.5%
10% most volatile stocks in AU Market16.7%
10% least volatile stocks in AU Market4.3%

Stable Share Price: M7T is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: M7T's weekly volatility (8%) has been stable over the past year.

About the Company

2007n/aMike Lampron

Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises worldwide. It operates through two segments, Sale of Software Licenses and Rendering of Professional Services. The Company offers enterprise diagnostic viewing solutions that include eUnity Enterprise Viewer and eUnity Diagnostic Viewer.

Mach7 Technologies Fundamentals Summary

How do Mach7 Technologies's earnings and revenue compare to its market cap?
M7T fundamental statistics
Market CapAU$143.30m
Earnings (TTM)-AU$2.60m
Revenue (TTM)AU$26.30m


P/S Ratio


P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
M7T income statement (TTM)
Cost of RevenueAU$17.76m
Gross ProfitAU$8.53m
Other ExpensesAU$11.13m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date


Earnings per share (EPS)-0.011
Gross Margin32.45%
Net Profit Margin-9.90%
Debt/Equity Ratio0%

How did M7T perform over the long term?

See historical performance and comparison
New valuation analysis is now available for all ASX stocks. This is in beta.

Future Growth

How is Mach7 Technologies forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score


Future Growth Score 4/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: M7T is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.8%).

Earnings vs Market: M7T is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: M7T's is expected to become profitable in the next 3 years.

Revenue vs Market: M7T's revenue (10.6% per year) is forecast to grow faster than the Australian market (4.7% per year).

High Growth Revenue: M7T's revenue (10.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: M7T is forecast to be unprofitable in 3 years.

Past Performance

How has Mach7 Technologies performed over the past 5 years?

Past Performance Score


Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: M7T is currently unprofitable.

Growing Profit Margin: M7T is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: M7T is unprofitable, but has reduced losses over the past 5 years at a rate of 31.2% per year.

Accelerating Growth: Unable to compare M7T's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: M7T is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (10.6%).

Return on Equity

High ROE: M7T has a negative Return on Equity (-4.37%), as it is currently unprofitable.

Financial Health

How is Mach7 Technologies's financial position?

Financial Health Score


Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: M7T's short term assets (A$29.8M) exceed its short term liabilities (A$8.3M).

Long Term Liabilities: M7T's short term assets (A$29.8M) exceed its long term liabilities (A$10.5M).

Debt to Equity History and Analysis

Debt Level: M7T is debt free.

Reducing Debt: M7T has no debt compared to 5 years ago when its debt to equity ratio was 0.2%.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable M7T has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: M7T is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 53.1% per year.


What is Mach7 Technologies's current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate M7T's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate M7T's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if M7T's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if M7T's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as M7T has not reported any payouts.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Mike Lampron





Mr. Michael Lampron, also known as Mike, serves as Managing Director and Director of Mach7 Technologies Limited since June 24, 2019 and also serves as Chief Executive Officer. With over 20 years ofexperie...

CEO Compensation Analysis

Compensation vs Market: Mike's total compensation ($USD442.63K) is above average for companies of similar size in the Australian market ($USD285.05K).

Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.

Leadership Team

Experienced Management: M7T's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.

Board Members

Experienced Board: M7T's board of directors are considered experienced (3.3 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: M7T insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Mach7 Technologies Limited's employee growth, exchange listings and data sources

Key Information

  • Name: Mach7 Technologies Limited
  • Ticker: M7T
  • Exchange: ASX
  • Founded: 2007
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Implied Market Cap: AU$143.296m
  • Shares outstanding: 238.83m
  • Website:

Number of Employees


  • Mach7 Technologies Limited
  • 120 Kimball Avenue
  • Suite 210
  • South Burlington
  • Vermont
  • 5403
  • United States


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/19 00:00
End of Day Share Price2022/05/19 00:00
Annual Earnings2021/06/30

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.